CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $122.33B, higher than 95% of all stocks globally
- PositionOperating margin is 33.7%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations12 currently firing — 12
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
122.33BUSDvs all stocks (USD)
Trailing P/E
39.70xvs Medical Instruments & Supplies peers
Revenue (TTM)
11.03BUSDvs all stocks (USD)
Profit Margin
28.45%vs Medical Instruments & Supplies peers
Beta
1.46xvs all stocks
52-Week Change
-33.07%vs all stocks
Market Capitalization
122.33BUSDvs all stocks (USD)
Enterprise Value
113.69BUSDvs all stocks (USD)
Trailing P/E
39.70xvs Medical Instruments & Supplies peers
Forward P/E
28.83xvs Medical Instruments & Supplies peers
PEG Ratio
1.55xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
11.09xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
7.01xvs Medical Instruments & Supplies peers
Enterprise to Revenue
10.30xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
27.27xvs Medical Instruments & Supplies peers
Profit Margin
28.45%vs Medical Instruments & Supplies peers
Operating Margin
33.75%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
10.54%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
17.42%vs Medical Instruments & Supplies peers
Revenue (TTM)
11.03BUSDvs all stocks (USD)
Revenue per Share (TTM)
31.07USDUpdated Jul 19, 2026Quarterly Revenue Growth
18.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
7.37BUSDvs all stocks (USD)
EBITDA (TTM)
3.62BUSDvs all stocks (USD)
Net Income (TTM)
3.14BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
24.30%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
3.28BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
2.86BUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
117.70MUSDFY2025 · Dec 31, 2025Revenue
10.06BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
3.42BUSDFY2025 · Dec 31, 2025Gross Profit
6.64BUSDFY2025 · Dec 31, 2025Operating Income
2.95BUSDvs all stocks (USD)
Pre-tax Income
3.31BUSDFY2025 · Dec 31, 2025Income Tax Expense
434.80MUSDFY2025 · Dec 31, 2025Net Income
2.88BUSDFY2025 · Dec 31, 2025EBIT
2.95BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
3.62BUSDFY2025 · Dec 31, 2025Research & Development
1.31BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
2.38BUSDFY2025 · Dec 31, 2025Non-operating Interest Income
365.90MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.88BUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-20.60MUSDFY2025 · Dec 31, 2025Operating Cash Flow
3.28BUSDFY2025 · Dec 31, 2025Free Cash Flow
2.74BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.41BUSDFY2025 · Dec 31, 2025Income Tax Paid
537.90MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.88BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
677.10MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
19.10MUSDFY2025 · Dec 31, 2025Stock-based Compensation
788.20MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-301.70MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
57.90MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-841.40MUSDFY2025 · Dec 31, 2025Capital Expenditures
-539.80MUSDFY2025 · Dec 31, 2025Net Acquisitions
-13.90MUSDFY2025 · Dec 31, 2025Purchase of Investments
-1.22BUSDFY2025 · Dec 31, 2025Sale of Investments
2.44BUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
665.80MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-2.30BUSDFY2025 · Dec 31, 2025Other Financing Charges
-419.10MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.71BUSDFY2025 · Dec 31, 2025Shares Outstanding
354.16MSharesUpdated Jul 19, 2026Float Shares
352.03MSharesUpdated Jul 19, 2026Shares Short
7.32MSharesUpdated Jul 19, 2026Short Ratio
2.79daysvs all stocks
Short % of Shares Outstanding
2.08%vs all stocks
% Held by Insiders
0.51%vs all stocks
% Held by Institutions
90.44%vs all stocks
Total Cash (MRQ)
8.63BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
24.36USDUpdated Jul 19, 2026Total Debt (MRQ)
0.00USDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
6.43xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
49.31USDUpdated Jul 19, 2026Total Assets
20.46BUSDvs all stocks (USD)
Total Current Assets
9.78BUSDFY2025 · Dec 31, 2025Total Liabilities
2.52BUSDFY2025 · Dec 31, 2025Total Non-current Assets
10.68BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
510.80MUSDFY2025 · Dec 31, 2025Total Current Liabilities
2.01BUSDFY2025 · Dec 31, 2025Cash
514.90MUSDFY2025 · Dec 31, 2025Cash Equivalents
2.85BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.37BUSDFY2025 · Dec 31, 2025Other Short-term Investments
2.57BUSDFY2025 · Dec 31, 2025Accounts Receivable
1.53BUSDFY2025 · Dec 31, 2025Inventory
1.84BUSDFY2025 · Dec 31, 2025Accounts Payable
255.10MUSDFY2025 · Dec 31, 2025Deferred Revenue
506.70MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
225.80MUSDFY2025 · Dec 31, 2025Common Stock (Book)
400.00KUSDFY2025 · Dec 31, 2025Retained Earnings
7.01BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
17.94BUSDvs all stocks (USD)
52-Week Low
344.55USDUpdated Jul 19, 202652-Week High
603.88USDUpdated Jul 19, 202652-Week Change
-33.07%vs all stocks
Beta
1.46xvs all stocks
50-Day MA
416.97USDUpdated Jul 19, 2026200-Day MA
486.56USDUpdated Jul 19, 2026Avg 10-Day Volume
4.02MSharesUpdated Jul 19, 2026Avg 30-Day Volume
3.02MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
8.70USDUpdated Jul 19, 202612 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 33.7%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: 0.34Industry median: 0.12Industry P95: 0.33Peers compared: 109
Profit margin is 28.4%, higher than 95% of its Medical Instruments & Supplies peers (median 8.5%)Significant
Profit margin: 0.28Industry median: 0.08Industry P95: 0.28Peers compared: 109
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.2×)Notable
Debt-to-equity: 0.00Industry median: 0.20Industry P5: 0.01Peers compared: 109
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.79
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $122.33B, higher than 95% of all stocks globallySignificant
Market cap (USD): 122,334,932,425Global P95: 25,614,208,870.135
Levered free cash flow is $2.86B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 2,856,000,000Global P95: 1,123,592,359.78
Revenue is $11.03B, above the global median of $520.53MNotable
Revenue (USD): 11,034,399,744Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Air Liquide S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Corning Incorporated
Tier 1ProductionThroughput-Bound ConversionFlowRule
Delta Electronics Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Trane Technologies plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Danaher Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
China Yangtze Power Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Cambricon Technologies Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
ASE Technology Holding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhongji Innolight Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Midea Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Argosy Research Inc.
12 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsCash Backing With Revenue And Income StreaksFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityMulti-Year FCF With Growth And Margin
Classys Inc.
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsCash Backing With Revenue And Income StreaksFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsMulti-Year FCF With Growth And Margin
Shanghai Bochuan Electronic Co., Ltd.
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsCash Backing With Revenue And Income StreaksFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsMulti-Year FCF With Growth And Margin